COVID-19: Neurological Considerations in Neonates and Children

Children (Basel). 2020 Sep 10;7(9):133. doi: 10.3390/children7090133.

Abstract

The ongoing worldwide pandemic of the novel human coronavirus SARS-CoV-2 and the ensuing disease, COVID-19, has presented enormous and unprecedented challenges for all medical specialists. However, to date, children, especially neonates, have been relatively spared from the devastating consequences of this infection. Neurologic involvement is being increasingly recognized among adults with COVID-19, who can develop sensory deficits in smell and taste, delirium, encephalopathy, headaches, strokes, and peripheral nervous system disorders. Among neonates and children, COVID-19-associated neurological manifestations have been relatively rare, yet reports involving neurologic dysfunction in this age range are increasing. As discussed in this review, pediatric neurologists and other pediatric specialists should be alert to potential neurological involvement by this virus, which might have neuroinvasive capability and carry long-term neuropsychiatric and medical consequences.

Keywords: COVID-19; SARS-CoV-2; brain; coronavirus; cytokine storm; neonate; neurodevelopment; neuroinflammation; neurological; neurotropism.

Publication types

  • Review